To the best of our knowledge, this is the first study to explore the clinical value and underlying molecular mechanisms of TMEM147 in HCC, highlighting the potency of TMEM147 as a diagnostic and prognostic biomarker and a therapeutic target for HCC. The gene discussed is TMEM147; the disease is hepatocellular carcinoma.